Cargando…
A novel artificial intelligence protocol to investigate potential leads for Parkinson's disease
Previous studies have shown that small molecule inhibitors of NLRP3 may be a potential treatment for Parkinson's disease (PD). NACHT, LRR and PYD domains-containing protein 3 (NLRP3), heat shock protein HSP 90-beta (HSP90AB1), caspase-1 (CASP1) and cellular tumor antigen p53 (TP53) have signifi...
Autores principales: | Chen, Zhi-Dong, Zhao, Lu, Chen, Hsin-Yi, Gong, Jia-Ning, Chen, Xu, Chen, Calvin Yu-Chian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Royal Society of Chemistry
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9054719/ https://www.ncbi.nlm.nih.gov/pubmed/35520357 http://dx.doi.org/10.1039/d0ra04028b |
Ejemplares similares
-
Novel and versatile artificial intelligence algorithms for investigating possible GHSR1α and DRD1 agonists for Alzheimer's disease
por: Tang, Zi-Qiang, et al.
Publicado: (2021) -
Investigation of the Novel Lead of Melanocortin 1 Receptor for Pigmentary Disorders
por: Tang, Hsin-Chieh, et al.
Publicado: (2014) -
TCMBank: bridges between the largest herbal medicines, chemical ingredients, target proteins, and associated diseases with intelligence text mining
por: Lv, Qiujie, et al.
Publicado: (2023) -
Artificial Intelligence-Based Application to Explore Inhibitors of Neurodegenerative Diseases
por: Deng, Leping, et al.
Publicado: (2020) -
In Silico Investigation of Potential TRAF6 Inhibitor from Traditional Chinese Medicine against Cancers
por: Chen, Kuan-Chung, et al.
Publicado: (2014)